Biblio

Export 623 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
R. Olmos-Villaseñor, Sepulveda-Silva, C., Julio-Ramos, T., Fuentes-Lopez, E., Toloza-Ramirez, D., Santibañez, R. A., Copland, D. A., and Mendez-Orellana, C., Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis., J Alzheimers Dis, vol. 95, no. 1, pp. 1-12, 2023.
B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
R. Ono, Sakurai, T., Sugimoto, T., Uchida, K., Nakagawa, T., Noguchi, T., Komatsu, A., Arai, H., and Saito, T., Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES., J Alzheimers Dis, vol. 92, no. 2, pp. 487-498, 2023.
M. Ángel Ontiveros-Torres, Labra-Barrios, M. Luisa, Díaz-Cintra, S., Aguilar-Vázquez, A. Ruth, Moreno-Campuzano, S., Flores-Rodríguez, P., Luna-Herrera, C., Mena, R., Perry, G., Florán-Garduño, B., Luna-Muñoz, J., and Luna-Arias, J. Pedro, Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse., J Alzheimers Dis, vol. 52, no. 1, pp. 243-69, 2016.
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2., J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
S. V. Ovsepian and O'Leary, V. B., Neuronal activity and amyloid plaque pathology: an update., J Alzheimers Dis, vol. 49, no. 1, pp. 13-9, 2016.
P
M. Pacheco Pachado, Casas, A. I., Elbatreek, M. H., Nogales, C., Guney, E., Espay, A. J., and Schmidt, H. H. H. W., Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes., J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease., J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
E. L. Paley, Merkulova-Rainon, T., Faynboym, A., Shestopalov, V. I., and Aksenoff, I., Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1531-1540, 2018.
R. F. Palmer and Royall, D. R., Future Dementia Severity is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope., J Alzheimers Dis, vol. 49, no. 2, pp. 521-9, 2016.
Y. Pan, Liu, R., Terpstra, E., Wang, Y., Qiao, F., Wang, J., Tong, Y., and Pan, B., Dysregulation and diagnostic potential of microRNA in Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 1-12, 2016.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project., J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
B. Papotti, Palumbo, M., Adorni, M. Pia, Elviri, L., Chiari, A., Tondelli, M., Bedin, R., Baldelli, E., Lancellotti, G., Lupo, M. Giovanna, Ferri, N., Bertolotti, M., Bernini, F., Mussi, C., and Zimetti, F., Influence of genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum., J Alzheimers Dis, vol. 102, no. 1, pp. 162-172, 2024.
M. A. Parra, Barriers to Effective Memory Assessments for Alzheimer's Disease., J Alzheimers Dis, vol. 90, no. 3, pp. 981-988, 2022.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
L. Pasquini, Scherr, M., Tahmasian, M., Myers, N. E., Ortner, M., Kurz, A., Förstl, H., Zimmer, C., Grimmer, T., Akhrif, A., Wohlschläger, A. M., Riedl, V., and Sorg, C., Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 51, no. 1, pp. 313-26, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium., J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
S. Patel, Wei, J., Shi, Z., Rifkin, A. S., S Zheng, L., Gelfman, E., Duggan, D., Helfand, B. T., Hulick, P. J., and Xu, J., Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers., J Alzheimers Dis, vol. 94, no. 2, pp. 483-489, 2023.
K. J. Peck, Girard, T. A., Russo, F. A., and Fiocco, A. J., Music and Memory in Alzheimer's Disease and The Potential Underlying Mechanisms., J Alzheimers Dis, vol. 51, no. 4, pp. 949-59, 2016.
F. Nørregaar Pedersen, Stokholm, L., Pouwer, F., Rubin, K. Hass, Peto, T., Frydkjær-Olsen, U., Thykjær, A. Suhr, Andersen, N., Andresen, J., Bek, T., La Cour, M., Heegaard, S., Højlund, K., Kawasaki, R., Hajari, J. Nouri, Kyvik, K. Ohm, Laugesen, C. Schmidt, Schielke, K. Christina, Simó, R., and Grauslund, J., Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study., J Alzheimers Dis, vol. 86, no. 1, pp. 451-460, 2022.
A. Pedrinolla, Venturelli, M., Fonte, C., Munari, D., Benetti, M. Vittoria, Rudi, D., Tamburin, S., Muti, E., Zanolla, L., Smania, N., and Schena, F., Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study., J Alzheimers Dis, vol. 61, no. 4, pp. 1599-1609, 2018.
C. D. Pereira, Martins, F., Wiltfang, J., Silva, O. A. B. da Cru, and Rebelo, S., ABC Transporters Are Key Players in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 463-485, 2018.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization., Neurology, vol. 74, no. 3, pp. 201-9, 2010.
J. R. Petrella, Michael, A. M., Qian, M., Nwosu, A., Sneed, J., Goldberg, T. E., Devanand, D. P., and P Doraiswamy, M., Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial., J Alzheimers Dis, vol. 91, no. 1, pp. 483-494, 2023.

Pages